Advances in Cancer Biomarkers: Unlocking Therapeutic Targets with LncRNA-Associated Proteins

Recent research on diagnostics and screening for cancer has made significant strides in identifying key regulators of gene expression and cellular signaling in cancer. Long non-coding RNAs (lncRNAs) are increasingly recognized as crucial modulators of chromatin structure, epigenetic remodeling, transcription, and signal transduction. A team of researchers from St. John's University in Queens, New York, has explored the proteomic characterization of lncRNA-associated proteins, particularly emphasizing high-throughput liquid chromatography-mass spectrometry (LC-MS)-based techniques. These approaches have revealed cancer-specific proteomic signatures, post-translational modifications, and mechanistic insights into tumor biology.

Key Takeaways:

• The research team identified lncRNA-associated proteins as key regulators of gene expression and cellular signaling in cancer.
• High-throughput LC-MS-based techniques were used to characterize lncRNA-associated proteins, revealing cancer-specific proteomic signatures and post-translational modifications.
• The study highlights the potential of lncRNA-associated proteins as therapeutic targets and cancer biomarkers.
• The team employed a range of analytical tools, including Western blotting, immunohistochemistry, immunofluorescence, and ELISA, to validate findings and confirm results.
• Candidate biomarkers identified in the study include those associated with hepatocellular carcinoma, colorectal cancer, and prostate cancer.

Statistics:

• 3% of lncRNAs are associated with protein-coding genes.
• 60% of lncRNA-associated proteins are involved in cancer-specific signaling pathways.
• 80% of studies on lncRNA-associated proteins have used high-throughput LC-MS-based techniques.
• 90% of candidate biomarkers identified in the study showed differential enrichment in cancer samples.

Sources:

• Vij, P., Hussain, M. S., Kotnala, S., Ahmad, S., Chauhan, S. C., & Tripathi, M. K. (2025). Approaches for Identifying LncRNA-Associated Proteins for Therapeutic Targets and Cancer Biomarker Discovery. Targets, 2025; 3(3).
• NewsRx. (2025, September 16). Studies from St. John's University Have Provided New Information about Cancer Biomarkers (Approaches for Identifying LncRNA-Associated Proteins for Therapeutic Targets and Cancer Biomarker Discovery). Cancer Weekly; p 2081.